GHRH analogues: CJC-1295 with and without DAC
CJC-1295 exists in two forms that are routinely confused, and the difference is the single most important thing to get right on this shelf. The DAC version carries a Drug Affinity Complex that binds serum albumin, extending half-life from minutes to days and producing a sustained elevation in GH and IGF-1. CJC-1295 without DAC — properly Modified GRF (1-29) — has a half-life measured in minutes and produces a sharp pulse instead. The literature treats them as genuinely different tools: sustained exposure and pulsatile exposure have different downstream effects on receptor sensitivity. Tesamorelin is the GHRH analogue with the most developed clinical record, studied specifically for its effect on visceral adipose tissue.





